Answers are grounded in this paper and cite their sources.
Multimodal imaging agents provide unique opportunities to probe disease states in vivo. The development of polymeric molecular imaging agents that combine the high‐resolution capabilities of MRI with other more sensitive techniques leads to significant possibilities for increasing our understanding of biological processes in live animals. To fully utilise this capability, advanced architectural polymers are being developed in which the material properties of the multimodal imaging agent are underpinned by a strong understanding of the underlying synthetic and physical chemistry of the macromolecules. In this report, the development of new polymers as multimodal imaging agents utilising MRI for preclinical in vivo studies is described.
No takes yet. Share an insight, caveat, or question.
Kristofer J. Thurecht (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: